Search

everythinglearnresearchcommunity

for

Search:↓

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Propylthiouracil treatment can cause hair loss.

Chronic telogen effluvium is a condition where there is prolonged shedding of hair.

Botulinum toxin A helped a patient recover from dissecting folliculitis when antibiotics failed.

FUT effectively treats male-pattern hair loss with high satisfaction.

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Impaired autophagy may cause hair loss by triggering early catagen.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Hair growth in alopecia areata is hindered due to impaired cell activity in the surrounding tissue.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Alopecia areata is linked to reduced T cell function and auto-immunity.

The newborn's skin condition improved over time, leaving only lighter skin patches.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Acitretin effectively improved the woman's skin condition.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.